Murine macrophage clones were generated from thymus, spleen, brain, and bone marrow by in vitro immortalization with recombinant retroviruses carrying an avian v-myc oncogene. The cloned cell lines express F4/80 molecules, exert phagocytosis, have nonspecific esterase activ-
ity, and express class II molecules after interferon y activation. The macrophage clones are diploid and their karyotypes have remained stable for >3 years in culture. After the macrophage clones were activated, their pattern of cytokine production was investigated. Functional heterogeneity in cytokine transcription was demonstrated: one of six liposaccharide-activated macrophages was unable to transcribe interleukin la, whereas all of the liposaccharide-activated clones were able to transcribe tumor necrosis factor a. Interleukin 6 production was detected in three of six clones. The production of nitrite and tumor necrosis factor a as effector molecules ofcytotoxicity was detected in all clones, thus showing that a single macrophage can exert more than one cytotoxic mechanism. The results indicate that immortalized and cloned macrophages have a differentially regulated expression of cytokine genes, adding further evidence for the existence of functional heterogeneity among cloned macrophages. This heterogeneity seems to derive from differentiation-related mechanisms rather than from external constraints.
Cells of monocyte/macrophage lineage originate from a common stem cell and seed multiple organs (1, 2) . After having entered a tissue, monocytes differentiate into resident macrophages and display a broad range of functional properties (3, 4) . Substantial knowledge about the heterogeneity of macrophage functions has been accumulated (5, 6 ), but it is not yet known whether this heterogeneity is brought about by developmentally programed mechanisms or by environmental influences.
It is commonly believed that the functional heterogeneity of macrophages is the result of external activation rather than an inherent characteristic of differently programed macrophage subpopulations. However, this view is in contrast with recent data providing evidence for the transient expression of cytokines in macrophages during their differentiation in vitro (7) and with data showing the existence of divergent functional phenotypes at the precursor level (8) . These results indicate that macrophage heterogeneity might be due to developmental mechanisms through the hierarchical and transient expression of various functions during differentiation and homing. Hence, analysis of cells of monocyte/ macrophage lineage, isolated as individual clones from various tissues, could help in clarifying this important issue.
Somatic cell hybrids from bone marrow-derived macrophages have already been cloned and the development of the macrophage hybrids according to divergent differentiation programs has been taken as evidence for separate progenitor subsets (8) . However, one drawback of these hybrids is their aneuploidy, which makes it difficult to distinguish the influence of genes from the parental tumor cell on the functions of the resulting hybrid.
As an alternative, spleen or bone marrow cloned macrophages, which can be grown for some time in the presence of colony-stimulating factor 1 (CSF-1) or granulocyte/macrophage CSF, have been studied (7, 9) . Unfortunately, this approach does not yield very large numbers of cells so that simultaneous molecular, biochemical, and functional characterization has not yet been possible.
In a third approach, cloned macrophages have been obtained by means of retroviral transformation and, by using the J2 retrovirus, which carries the mil/rafand myc oncogenes, bone marrow-derived macrophages have been immortalized (10) .
In line with this approach, we have recently generated oncogenic murine retroviruses that transduce only one oncogene, the v-myc gene of the avian MH2 retrovirus (11, 12) . These recombinant viruses acutely immortalize in vitro macrophages from thymus, spleen, bone marrow, and brain tissues by establishing an autocrine loop based on the concomitant activation ofmacrophage CSF (M-CSF) and M-CSF receptor genes (13) . The immortalized cells can be cloned and have retained cell-specific constitutive and inducible functions for >3 years (13) .
The availability ofcloned macrophages from various tissues allowed us to address the question as to whether functional heterogeneity among similarly activated macrophages can be shown at a clonal level. Cytokine expression shows that there is clonal heterogeneity among macrophages and their functional regulation might depend on their intrinsic properties.
MATERIALS AND METHODS
Cell Culture and Viral Infection. Primary cultures of hemopoietic tissues from different mouse strains were seeded and infected with either the VN11 or the VN13 retrovirus, as described (12, 13) .
Proliferating cells from BALB/c, BlOD2/0, and B1OD2/N thymuses and from C57BL/6 spleens were cloned and characterized. The immortalization of microglial cell clones obtained from embryonic brain tissue has been described (12 (14) . Fc receptors (FcRs) were detected by incubating cells with a purified IgG fraction of normal mouse serum as primary antibody.
Fluorescein isothiocyanate (FITC)-conjugated F(abh goat anti-mouse immunoglobulin was used as secondary antibody. Expression of tumor necrosis factor a (TNF-a) was tested on macrophages and microglial cells incubated for 16 hr with and without lipopolysaccharide (LPS; 10 ,g/ml) and then stained with anti-TNF-a antibody. To avoid FcR nonspecific binding, cells were preincubated with normal mouse serum and incubated with a 1:50 diluted rabbit antiserum specific for recombinant mouse TNF-a (Genzyme). Goat anti-rabbit FITC antibody (Cappel Laboratories), diluted 1:50, was used as secondary antibody. All staining analyses were performed using a FACStar Plus cytofluorimeter (Becton Dickinson; available courtesy of A. Mantovani, M. Negri Institute, Milan).
Karyotypic Analysis. Metaphasic plates from the cell clones described in this report were prepared after 2 hr of colcemid treatment and a standard hypotonic shock. Cells were fixed in methyl alcohol/acetic acid, 3:1 (vol/vol), and stained in 5% Giemsa in phosphate buffer (pH 6.8). Ten metaphasic plates were screened, and numerical and morphological anomalies were recorded.
Northern Blot Analysis. Northern blot analysis was performed as described (12) . The TNF-a probe was a HindIIEcoRI fragment containing about 350 base pairs (bp) of exon 4 (15) . The mouse interleukin la (IL-la) cDNA probe was a 418-bp Pst I-Pvu II fragment of the IL-1 1301 clone (16 Using this approach, we were able to immortalize and clone macrophages derived from thymus, spleen, and brain. In each experiment, only monocyte/macrophage lineage cells grew. Mock control cultures, infected with retroviruses carrying other oncogenes and grown without the addition of growth factors in the culture medium, died in 3-4 weeks. Twenty-five macrophage lines were obtained from 10 independent infections. Among these, macrophages from bone marrow, peritoneum, and liver were also immortalized and cloned (data not shown). For this investigation, spleen (MS) and thymus-derived clones (M, MT) were further analyzed and compared with the microglial cell clones (N) already described (12) .
Karyotypic and Phenotypic Characterization. Karyotypic analysis of the metaphasic plates from the clones described in this report detected no morphological anomalies. All ofthe clones were diploid (40 chromosomes) as shown in Fig. 1 . Cells also exhibited nonspecific esterase activity and FcRmediated phagocytosis of opsonized sheep erythrocytes (data not shown). Phenotypic analysis of these clones was performed by cytofluorimetry and the results are shown in Fig. 2 . All of the examined clones expressed the F4/80 and Macl mouse macrophage marker as well as FcRs. Expression of MHC class II molecules is shown in Fig. 3 . No constitutive expression of IA or IE molecules was detectable, but in all clones expression was readily induced after IFN-y treatment. These results clearly show that the clones obtained are macrophages. To analyze the functional properties of these clones further, cytokine expression and cytotoxicity were assessed.
Cytokine Gene Expression. TNF-a and IL-la expression was demonstrated by Northern blot analysis using the mRNA of LPS-activated macrophage clones. As shown in Fig. 4 of the tested clones were able to transcribe TNF-a after LPS activation. In contrast, one of these clones, the Ml clone, was unable to transcribe detectable amounts of IL-la, although it did respond to LPS and transcribed the TNF-a gene (Fig. 5) . This same clone, as well as clone M2/1, was also unable to produce IL-6 after treatment with either LPS or rIL-1,3, although this cytokine was readily induced after LPS treatment in all of the other examined clones (Table 1 ). These results demonstrate that heterogeneity in the pattern of cytokine expression can be found in cloned macrophages.
Cytotoxic Activity of Macrophage Clones. NOj /NOJdependent cytotoxicity. The main cytolytic mechanism of activated macrophages against P815 cells has been shown to be the production of NO /NO-from L-arginine (21) . All of the macrophage clones were capable of releasing NO2 after IFN-y plus LPS activation (Table 2 ). Interestingly, with some clones, IFN-y alone was nearly as effective as IFN-y plus LPS in inducing the release of NOj ( Table 2) . The mouse macrophage cell line RAW was included for comparison, since these cells release high levels of NO- (22) .
In addition, as shown in Fig. 6 , representative clones were as capable of killing P815 targets in response to LPS and IFN-y as the normal bone marrow-derived macrophages (BM 0) used as reference cells in the cytotoxicity assay.
TNF-a-dependent cytotoxicity. TNF-a-mediated cytotoxicity was tested by using the MTT colorimetric assay on WEHI 164.13 cells, which are TNF-a-sensitive targets. The results from representative clones are shown in Fig. 7 . All macrophage clones efficiently killed WEHI 164.13 cells after LPS activation (Fig. 7A) . Addition of a rabbit antiserum against recombinant mouse TNF-a was able to block this killing activity (Fig. 7B) , thus identifying TNF-a as the effector molecule. Normal rabbit serum was unable to block the cytotoxicity (data not shown). Cell-free supernatants from macrophage cell cultures showed a very low level of cytotoxicity on WEHI 164.13 targets (Fig. 7C) when compared to the values of the cell-mediated killing obtained by using the respective cells (Fig. 7A) . In the same experiment, recombinant mouse TNF-a (0.5 pg/ml) was able to induce 60% killing of the same targets. Finally, rTNF-a-specific rabbit antiserum staining showed, by fluorescence-activated 24 Cell clones were incubated with rIFN-y (10 units/ml) and/or LPS (10 ng/ml) for 20 hr. NO-concentrations (nmol per well) were determined by using NaNO2 as a standard. Results are expressed as the mean ± SD of six replicates. cell sorter (FACS) analysis, that membrane-bound TNF-a was the major form of TNF-a produced by the cloned cells (Fig. 7D) . These results show that a single macrophage clone can exert tumoricidal and cytotoxic activity through activation of TNF-a and NO--mediated cytolytic mechanisms.
DISCUSSION
Retrovirally immortalized and cloned macrophages derived from thymus, spleen, bone marrow, or brain were obtained from various mouse strains. The macrophage clones have retained constitutive and inducible functional activities for >3 years. These clones are diploid and no gross chromosome alterations have been detected. Consequently, retroviral immortalization of macrophages represents a valuable alternative to macrophage hybridomas, which are known to be unstable. Furthermore, there is no introduction of new genes, which may directly influence the function of the resulting hybrid.
Despite the absence of any kind of selection or special growth conditions, retroviruses released by N11 or N13 producer cells were able to immortalize the macrophages derived from thymus, spleen, bone marrow, and brain. The molecular mechanisms involved in the induction of in vitro macrophage proliferation after VN11 infection were investigated and, in the infected clones, we observed the concomitant expression of M-CSF receptor and M-CSF growth factor genes (13) . This suggests the presence of a viral infection-triggered autocrine loop involving the transcription and production of M-CSF. In addition, the macrophage clones could also grow in vivo in nude mice (13) . The availability of cloned macrophages allowed us to analyze two major functional properties of the activated macrophages: tumoricidal activity and cytokine expression. The cytolytic mechanisms of activated macrophages include production of TNF-a molecules (23) (24) (25) and generation of L-argininedependent nitric oxide (NO) followed by NO-release (26) . analysis showed that membrane-bound TNF-a was the major TNF-a form present in these clones. This transmembrane protein (27) (28) (29) has been recently shown to mediate the killing of TNF-a-sensitive tumor cells (30, 31) .
We further examined the functional activation of the cloned macrophages by studying IL-la and TNF-a gene transcription. Activated macrophages had a heterogeneous cytokine expression. The IL-la gene was transcribed in five of the six LPS-activated macrophage clones, whereas TNF-a gene transcription was shown in all of them. IL-6 production was also heterogeneous, since two of five clones did not produce IL-6 after LPS activation. These results suggest the interesting possibility that macrophage subsets with different T-cell costimulatory capacities might exist. As far as cytokine production is concerned, this previously unrecognized heterogeneity in tissue macrophages has already been shown for T-cell clones (32) . In mice, two distinct subsets of activated T-helper lymphocytes exist: Thl, capable of producing IL-2 and IFN-y, and Th2, capable of producing IL-4, IL-5, and CSF-1 (32) . As in T cells, our results suggest that macrophage clones may have a differentially regulated expression of cytokine genes. These patterns of cytokine expression could be of relevance in macrophage-T-cell interaction.
The availability of macrophages with different genetic backgrounds and the possibility ofinducing class II gene expression in IFN-y-treated clones will permit antigen processing and presentation to be studied with cloned tissue macrophages. In fact, retroviral immortalization is not restricted to a particular strain ofmice. Preliminary data obtained from our macrophage clones show that clonal differences also exist in relation to the ability to present peptides. 
